# BYND — baseline

## Metadata

ticker: BYND
arm: baseline
judge_prompt_version: v2
context_sha256: bc45f8fa9fea685a0f275760a540179b6464d4c4ce62e088779ade4e13d4a186
llm_calls: 7
llm_endpoints: anthropic
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 223, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.93, "latency_s_total": 2.93, "parse_failure": 0, "prompt_tokens": 3224, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 319, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 4.228, "latency_s_total": 4.228, "parse_failure": 0, "prompt_tokens": 3197, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 183, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.211, "latency_s_total": 2.211, "parse_failure": 0, "prompt_tokens": 637, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 180, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.588, "latency_s_total": 2.588, "parse_failure": 0, "prompt_tokens": 630, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 181, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.22, "latency_s_total": 2.22, "parse_failure": 0, "prompt_tokens": 392, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 114, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 1.685, "latency_s_total": 1.685, "parse_failure": 0, "prompt_tokens": 304, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 1220, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 18.908, "latency_s_total": 18.908, "parse_failure": 0, "prompt_tokens": 1720, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "BYND",
  "company_name": "Beyond Meat, Inc.",
  "current_price": 8.25,
  "currency": "USD",
  "market_cap": 141850208.0,
  "forward_pe": -0.7914124,
  "week_52_high": 230.7,
  "week_52_low": 7.84,
  "revenue": 258844992.0,
  "net_income": 258864992.0,
  "profit_margin": 1.15852,
  "sector": "Consumer Defensive",
  "industry": "Packaged Foods"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-04-09",
    "summary": "ITEM 1A. RISK FACTORS. Risk Factor Summary We are providing the following summary of the risk factors to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors immediately following this summary as well as the other information in this report, including Item 7 , Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations , Note Regarding Forward-Looking Statements , and our consolidated financial statements and related notes, before deciding whether to invest in shares of our common stock. The risks and uncertainties described in this report may not be the only ones we face. If any of the risks actually occurs, our business, financial condition, operating results, cash flows and prospect"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-06",
    "summary": "ITEM 1A. RISK FACTORS. In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, in our 2025 10-K, as updated and supplemented below and in our subsequent filings. These risks could materially harm our business, operating results and financial condition. Additional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely affect our business, financial condition or future results. Risk Factors Risks Related to Our Business Our strategic repositioning to \u201cBeyond The Plant Protein Company\u201d may not be successful, and our failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context only contains risk factor disclosures from a filing, which represent just one section of these comprehensive documents.

To properly summarize the key takeaways from a 10-K or 10-Q, I would need access to additional critical sections such as:

- Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations
- Consolidated financial statements (balance sheet, income statement, cash flow statement)
- Results of operations and financial performance metrics
- Business overview and strategy
- Liquidity and capital resources analysis
- Executive compensation information
- Other material business developments

The risk factors alone do not provide sufficient information to characterize the overall financial health, operational performance, strategic direction, or key business developments that would constitute the main takeaways from these filings. To obtain a comprehensive summary, you would need to review the complete 10-K or 10-Q documents filed with the SEC.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

The company discloses risk factors across three main categories:

## Risks Related to Business Operations
- Adverse economic and political conditions, including inflation concerns, government shutdowns, and trade policy uncertainties
- History of losses and negative cash flows, with challenges in achieving profitability
- Reduced consumer confidence and spending patterns
- Weakness in the plant-based meat category with persistent demand declines
- Operational challenges including cost-reduction initiatives, workforce reductions, and leadership changes
- Difficulties in accurately forecasting demand and managing inventory
- Supply chain disruptions and reliance on limited suppliers
- Limited distributor network and customer consolidation risks
- Challenges in expanding into new markets and maintaining revenue growth
- Talent retention and workplace safety concerns
- Tariffs and trade restrictions affecting raw materials and finished goods

## Risks Related to Products
- Food safety incidents and product misbranding concerns
- Declining sales of flagship products
- Changing consumer preferences and trends
- Challenges in introducing new products or improving existing ones
- Price volatility and ingredient/packaging cost fluctuations

## Risks Related to Industry and Brand
- Increased competition and new market entrants
- Industry consolidation pressures
- Potential brand reputation damage from quality or health issues
- Challenges in maintaining and developing brand value

These risks could materially and adversely affect the company's business, financial condition, operating results, cash flows, and stock price.

## Pre-written sections (judge input)

### Financial Health

Beyond Meat trades at $8.25 per share with a market capitalization of $141.9 million, representing a dramatic decline from its 52-week high of $230.70. The company's forward P/E ratio of -0.79 indicates unprofitability on a forward-looking basis, though reported net income of $258.9 million against revenue of $258.8 million suggests accounting anomalies requiring scrutiny. With a profit margin of 115.9%, the financials appear distorted and warrant careful examination of underlying operational performance. The company faces significant execution risks related to its strategic repositioning as "Beyond The Plant Protein Company," as outlined in recent SEC filings. Overall, BYND presents a financially distressed profile with substantial valuation compression and operational challenges that demand investor caution.

### Recent Developments

Beyond Meat faces significant execution risks as it pursues a strategic repositioning to become "Beyond The Plant Protein Company," according to its most recent 10-Q filing from August 2026. The company's financial performance remains challenged, with a negative forward P/E ratio and a stock price of $8.25—down dramatically from its 52-week high of $230.70—reflecting investor concerns about profitability and market viability. The company's recent SEC filings emphasize multiple risk factors that could materially harm operations and financial condition, suggesting management acknowledges substantial headwinds in the competitive plant-based protein market. For investors, the combination of strategic uncertainty, depressed valuation, and highlighted business risks indicates BYND remains a highly speculative investment requiring close monitoring of execution on its repositioning strategy.

### SEC Filing Highlights

Unable to provide accurate SEC filing highlights at this time. The available data contains only risk factor disclosures and lacks critical sections necessary for a comprehensive summary, including Management's Discussion & Analysis (MD&A), consolidated financial statements, operational results, and liquidity analysis. To generate reliable takeaways from Beyond Meat's most recent 10-K or 10-Q, access to complete filing documents would be required. Please consult the full SEC filings or provide additional financial and operational data for proper analysis.

### Risk Factors

• **Persistent Profitability Challenges and Negative Cash Flows** — Beyond Meat has a history of losses and negative cash flows with ongoing difficulties achieving profitability, compounded by cost-reduction initiatives and workforce reductions that may impact operational efficiency and growth investments.

• **Declining Plant-Based Meat Category Demand** — The company faces structural headwinds from persistent weakness in the plant-based meat category and changing consumer preferences, with flagship product sales declining and challenges in accurately forecasting demand and managing inventory.

• **Competitive Pressures and Supply Chain Vulnerabilities** — Beyond Meat operates in an increasingly competitive market with new entrants and industry consolidation, while facing supply chain disruptions, reliance on limited suppliers, and tariff/trade restrictions that could materially impact costs and margins.

## Audited (Exec Summary + Outlook)

### Executive Summary
Beyond Meat is a plant-based protein company pursuing a strategic repositioning as "Beyond The Plant Protein Company," currently trading at $8.25 per share with a market capitalization of $141.9 million — a dramatic compression from its 52-week high of $230.70 that reflects deep investor skepticism about the company's path to profitability and the broader viability of the plant-based meat category. BYND is notable now precisely because its distressed valuation, anomalous reported financials, and acknowledged operational headwinds place it at a critical inflection point where the repositioning strategy either begins to demonstrate traction or the investment case deteriorates further. The single most important near-term variable is whether management can execute on its strategic repositioning in a way that stabilizes revenue and demonstrates a credible route to positive cash flow — without that, the remaining valuation support is difficult to justify.

### Outlook
The directional lean on BYND is **cautious**, and the weight of evidence would need to shift meaningfully before that view changes. On the headwind side, the company faces a compounding set of challenges: structural weakness in consumer demand for plant-based meat, intensifying competition, supply chain fragility, and a history of negative cash flows that cost-reduction measures alone have not resolved. The distorted reported financials add an additional layer of analytical uncertainty that makes it difficult to assess true operational health without access to complete MD&A and cash flow disclosures. On the tailwind side, the repositioning as "Beyond The Plant Protein Company" could, in principle, open adjacent markets and reduce dependence on the declining core plant-based burger category — but this remains an unproven thesis. Investors should watch the following variables closely: the pace and coherence of the repositioning strategy as evidenced in successive SEC filings; whether flagship product volume declines stabilize or accelerate; the trajectory of cash burn and any developments around liquidity or financing; and whether the competitive landscape shows signs of consolidation that could reduce pricing pressure. The view would become more constructive if the repositioning strategy produces measurable revenue stabilization, the anomalous financial figures are clarified and reflect genuine improvement in underlying operations, and cash flow trends show a credible path toward sustainability. Conversely, continued demand erosion, further workforce reductions that impair growth capacity, or supply chain disruptions that compress margins would reinforce the cautious stance and raise questions about long-term viability.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically identify every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the Executive Summary and Outlook sections, then evaluate each one.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "currently trading at $8.25 per share"
LABEL: SUPPORTED
REASON: The source data explicitly lists `"current_price": 8.25` for BYND.

---

CLAIM: "market capitalization of $141.9 million"
LABEL: SUPPORTED
REASON: Source data shows `"market_cap": 141850208.0`; $141,850,208 rounds to $141.9 million, within acceptable rounding.

---

CLAIM: "52-week high of $230.70"
LABEL: SUPPORTED
REASON: Source data explicitly lists `"week_52_high": 230.7`.

---

**OUTLOOK**

The Outlook section contains no specific quantitative figures, price targets, thresholds, ratios, metrics, percentages, named product milestones, or forward-looking numbers. All statements are qualitative or directional in nature (e.g., "structural weakness," "intensifying competition," "cautious," "unproven thesis"). There are no numerical claims to audit in this section.

---

**SUMMARY**

All three quantitative claims in the audited sections are directly supported by the raw source data. The Outlook section contains no quantitative or forward-looking numerical claims requiring verification.
